Beta-caryophyllene — a terpene found in black pepper, cloves, oregano, and cannabis — selectively activates the CB2 cannabinoid receptor, making it the only known dietary cannabinoid and the only terpene confirmed to directly bind a cannabinoid receptor.
Anyone interested in the entourage effect, dietary compounds that modulate the endocannabinoid system, non-psychoactive cannabinoid therapeutics, or the pharmacology of terpenes.
Beta-caryophyllene is the only terpene known to directly bind a cannabinoid receptor — and it is already in your spice rack.
The Backstory
In 2008, a team led by Jürg Gertsch at ETH Zurich published a three-word title in one of the most prestigious journals in science: "Beta-caryophyllene is a dietary cannabinoid."
Beta-caryophyllene is the spicy, peppery compound in black pepper. It is in cloves, oregano, cinnamon, rosemary, and hops. It is in cannabis, where it is typically one of the most abundant terpenes. It is in food you have eaten today.
And it directly activates a cannabinoid receptor.
This was not a theoretical prediction or an indirect observation. Gertsch showed that beta-caryophyllene binds the CB2 receptor with nanomolar affinity, functions as a full agonist, and reduces inflammation in living animals through this specific mechanism. It is the only terpene confirmed to directly bind a cannabinoid receptor — and it has been in your spice rack the entire time.
The Researcher
Jürg Gertsch's path to cannabinoid pharmacology was unusual. He studied cultural anthropology and neuroscience at the Universidad Central de Venezuela before turning to biochemistry at the Biozentrum Basel and the University of Sussex. His PhD at ETH Zurich was in natural product chemistry — the science of identifying pharmacologically active compounds in plants and other organisms.
This interdisciplinary background shaped his research question. Gertsch was not a cannabis researcher looking for active compounds in the plant. He was a natural products chemist interested in how dietary compounds interact with the endocannabinoid system. His question was broader: are there cannabinoids hiding in everyday food?
The answer turned out to be sitting in the pepper grinder.
After the beta-caryophyllene paper, Gertsch moved to the University of Bern, where he became a full professor and eventually co-founded Synendos Therapeutics — a company developing drugs that target endocannabinoid transport mechanisms. His research program continues to explore the intersection of diet, natural products, and the endocannabinoid system.
The Experiment
Gertsch and his eight co-authors across institutions in Switzerland, Germany, and the United States conducted a systematic investigation with three distinct phases:
How They Did It
How They Proved a Terpene Is a Cannabinoid
Binding assay
Used radioligand displacement assays to test whether beta-caryophyllene binds cannabinoid receptors. Result: selective binding to CB2 with Ki = 155 ± 4 nM. No significant binding to CB1.
This means beta-caryophyllene grabs onto CB2 receptors at concentrations achievable in biological systems, but does not touch CB1 — the receptor responsible for psychoactive effects
Functional assay
Measured whether binding translates to receptor activation. Tested GTPγS binding (a measure of G-protein coupling) and cAMP inhibition (a downstream signaling event). Result: beta-caryophyllene is a full CB2 agonist.
Binding alone would make it a ligand; functional activation makes it an agonist — it turns the receptor on
In vivo inflammation model
Fed beta-caryophyllene orally (5 mg/kg) to mice, then induced paw inflammation with carrageenan. Tested both wild-type mice and mice genetically engineered to lack CB2 receptors.
This is the elegant control: if the effect disappears when CB2 is absent, the mechanism is proven
The knockout control
In wild-type mice, oral beta-caryophyllene strongly reduced inflammation. In CB2 knockout mice, the exact same dose had no anti-inflammatory effect.
This proves the anti-inflammatory mechanism is specifically via CB2 — not some other pathway
Gertsch et al. (2008), PNAS 105(26):9099-9104
The CB2 knockout experiment is what elevates this paper from interesting to definitive. Many compounds reduce inflammation through various mechanisms. Showing that the effect completely vanishes when you remove CB2 from the equation proves that beta-caryophyllene is working through the endocannabinoid system — not through some other anti-inflammatory pathway.
The Numbers
155 nM
binding affinity (Ki) of beta-caryophyllene at the CB2 receptor. For pharmacological context, this is a moderate but clearly functional affinity — well within the range where biological effects occur. It is selective for CB2, meaning it does not activate CB1 (the receptor that produces the cannabis 'high'). At 5 mg/kg given orally, it produced significant anti-inflammatory effects in living mice — but only when CB2 receptors were present.
For comparison, THC binds CB1 with a Ki of roughly 10-40 nM. Beta-caryophyllene's CB2 affinity is lower but still pharmacologically meaningful — and because it is an abundant dietary compound with GRAS status, it is already widely consumed.
Gertsch et al. (2008), PNAS 105(26):9099-9104
Why This Study Matters for Cannabis
Beta-caryophyllene is one of the most abundant terpenes in cannabis. It is the peppery, spicy note in the aroma profile. Our terpene guide identifies it as one of the five most common terpenes across cannabis cultivars.
For the entourage effect debate, Gertsch's finding is the single strongest piece of evidence. When critics point out (correctly) that most cannabis terpenes do not directly activate CB1 or CB2 receptors, beta-caryophyllene is the exception. It is the one terpene for which direct cannabinoid receptor binding is unambiguously proven.
The Black Pepper Connection
One of the most widely repeated pieces of cannabis folk wisdom is that chewing black peppercorns can reduce cannabis-induced anxiety and paranoia. Neil Young famously endorsed this remedy. The mechanism has never been formally tested in humans, but Gertsch's finding provides a plausible pharmacological basis.
Myth vs. Reality
Chewing black pepper helps with cannabis anxiety because of some vague 'calming' property.
Black pepper is one of the richest dietary sources of beta-caryophyllene, which Gertsch proved is a selective CB2 agonist. CB2 activation modulates immune and inflammatory signaling without psychoactive effects. While no controlled trial has tested whether eating black peppercorns during a cannabis anxiety episode reduces symptoms via CB2 activation, the mechanism is pharmacologically plausible. Other compounds in black pepper (like piperine, an endocannabinoid uptake inhibitor) may also contribute.
The Evidence
Beta-caryophyllene binds CB2 at Ki = 155 nM and reduces inflammation via CB2 in mice. Reynoso-Moreno et al. (2017) showed that an endocannabinoid uptake inhibitor from black pepper produces anti-inflammatory effects in mice.
Gertsch et al. (2008); Reynoso-Moreno et al. (2017)
Beyond Cannabis: A Dietary Cannabinoid
The broader significance of this study extends beyond cannabis pharmacology. Gertsch showed that the endocannabinoid system — the body's own cannabinoid signaling network — is modulated by ordinary dietary compounds. You do not need to consume cannabis to engage your CB2 receptors. Every time you eat food seasoned with black pepper, oregano, or cinnamon, you are consuming a CB2 agonist.
This has implications for understanding the endocannabinoid system as a regulatory network that interfaces not just with endogenous signaling molecules but with the chemical environment of the diet. Gertsch later expanded on this idea in a 2017 review proposing that dietary cannabimimetic compounds may have shaped food preferences and metabolic adaptation over evolutionary timescales.
Process
Where You Find Beta-Caryophyllene
Black Pepper
One of the richest dietary sources. The compound contributes to pepper's characteristic spicy, woody aroma.
Cannabis
Typically one of the top 3-5 terpenes by concentration in cannabis flower. Contributes the peppery, spicy notes to cannabis aroma profiles.
Cloves
High concentrations in clove essential oil. Traditional use of cloves for pain and inflammation may involve CB2-mediated effects.
Oregano & Rosemary
Significant concentrations in the essential oils of common culinary herbs.
Cinnamon
Present in cinnamon bark oil. Another traditional anti-inflammatory spice with CB2 agonist activity via this compound.
Hops
Present in hops — the flavoring agent in beer. Cannabis and hops are botanical relatives (both in family Cannabaceae).
Gertsch et al. (2008); Russo (2011)
Is beta-caryophyllene psychoactive?
No. It binds CB2 selectively and does not activate CB1 — the receptor responsible for the cannabis "high." CB2 is primarily expressed in immune cells and is associated with anti-inflammatory and immunomodulatory effects. You can consume large amounts of beta-caryophyllene (as you do when eating peppered food) without any psychoactive effects.
Does this prove the entourage effect?
It proves one specific element: that at least one terpene in cannabis (beta-caryophyllene) directly activates a cannabinoid receptor (CB2). This is the strongest mechanistic evidence for a terpene-cannabinoid receptor interaction. However, the broader entourage effect hypothesis — that multiple terpenes synergistically enhance cannabinoid effects — involves other mechanisms and other terpenes for which direct receptor binding has not been confirmed.
How much beta-caryophyllene do I get from food?
Dietary intake varies widely. A heavily peppered meal might provide 10-50 mg. Whether this achieves pharmacologically meaningful CB2 activation in tissue is uncertain — the mouse study used 5 mg/kg, which would translate to roughly 350 mg for a 70 kg human (an amount far above typical dietary intake but achievable through supplements or concentrated essential oils).
Can I take beta-caryophyllene as a supplement?
Beta-caryophyllene supplements are commercially available and have FDA GRAS (Generally Recognized As Safe) status as a food additive. However, clinical trials for specific therapeutic applications in humans are limited. The preclinical evidence for anti-inflammatory effects is strong, but human dosing and efficacy data are still being developed.
Related Research
Terpenes, Cannabinoid Receptors, and the Entourage Effect
Gertsch's discovery of beta-caryophyllene as a CB2 agonist is the centerpiece of the debate over whether cannabis terpenes have genuine cannabinoid activity.
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Russo (2011)
The entourage effect review that made beta-caryophyllene famous — Russo highlighted it as the strongest evidence for terpene-cannabinoid receptor interaction
Terpenes do not directly activate CB1 or CB2 receptors
Santiago et al. (Finlay) (2020)
The counter-evidence: five common cannabis terpenes showed no CB1/CB2 activity. Beta-caryophyllene is the confirmed exception, not the rule.
Terpenes/terpenoids in cannabis: are they important?
Hanuš & Hod (2020)
Analytical chemistry of 108 cannabis chemotypes — measuring how much beta-caryophyllene (and other terpenes) is actually in the plant
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-AG cannabinoid activity
Ben-Shabat, Fride, Mechoulam et al. (1998)
The original entourage effect paper — inactive companions enhance endocannabinoid activity. Beta-caryophyllene extends this concept from endogenous to dietary compounds.
GPR55 as a novel cannabinoid receptor
Ryberg et al. (2007)
The discovery of GPR55 as an additional cannabinoid receptor — expanding the receptor landscape beyond CB1/CB2 that beta-caryophyllene engages
What the researchers found
Beta-caryophyllene selectively binds CB2 (Ki = 155 ± 4 nM) and is a functional agonist. Oral BCP at 5 mg/kg reduced inflammation in wild-type mice but not CB2 knockout mice, confirming cannabimimetic effects via CB2.
Why it matters
This is the only confirmed example of a terpene directly binding a cannabinoid receptor. It validates a piece of the entourage effect hypothesis at the receptor level, provides a mechanism for dietary modulation of the endocannabinoid system, and opens a new category of non-psychoactive cannabinoid therapeutics.
How the study worked
Radioligand binding assays to determine CB2 affinity. Functional assays (GTPγS binding, cAMP inhibition) to confirm agonist activity. In vivo carrageenan-induced paw edema model in wild-type and CB2 knockout mice to demonstrate anti-inflammatory effects via CB2.
What this study cannot tell us
The study demonstrated CB2 agonism and anti-inflammatory effects in mice, but clinical trials in humans are limited. The Ki of 155 nM is moderate — whether dietary intake of beta-caryophyllene from food or cannabis achieves sufficient tissue concentrations for CB2 activation in humans is debated. The anti-inflammatory effects shown are in an acute model; chronic applications are less well characterized.
How to read the evidence
Strong preclinical evidence: selective binding confirmed via radioligand assay, functional agonism confirmed, and in vivo effects demonstrated with CB2 knockout controls. Published in PNAS. However, human clinical trials for specific therapeutic applications are limited.
When this study was published
Published in 2008 — 18 years old. The core finding (CB2 binding) has been repeatedly confirmed. Beta-caryophyllene has become one of the most studied terpenes in cannabinoid pharmacology.
The bigger picture
This study bridged cannabis pharmacology and dietary science. It showed the endocannabinoid system is modulated not just by cannabis but by common dietary compounds. It provided the strongest evidence that at least one terpene in cannabis has genuine cannabinoid receptor activity, supporting one element of the entourage effect hypothesis.
Questions still open
- ["Do dietary levels of beta-caryophyllene from food achieve pharmacologically meaningful CB2 activation?","Could beta-caryophyllene supplements be developed as non-psychoactive anti-inflammatory cannabinoids?","Does beta-caryophyllene in cannabis contribute meaningfully to the entourage effect via CB2?","Does the folk remedy of chewing black peppercorns for cannabis anxiety work via CB2 activation?"]
Common questions
Is beta-caryophyllene actually a cannabinoid?
Does chewing black peppercorns really help with cannabis anxiety?
How much beta-caryophyllene is in cannabis?
Can I take beta-caryophyllene as a supplement?
Read the original research
Beta-caryophyllene is a dietary cannabinoid
Proceedings of the National Academy of Sciences
PNAS — one of the most cited multidisciplinary scientific journals in the world, lending extraordinary credibility to the claim that a common dietary terpene is a cannabinoid receptor ligand.
Citation
Gertsch, Jürg; Leonti, Marco; Raduner, Stefan; Racz, Ildiko; Chen, Jian-Zhong; Xie, Xiang-Qun; Altmann, Karl-Heinz; Karsak, Meliha; Zimmer, Andreas. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0803601105